Search results for

The second season of the HBO series premieres this month, and Fresh Air critic David Bianculli says "these young women — these girls — really are changing and growing and adapting to tough life in the big city."

Also: Death toll at 120 in wave of bombings in Pakistan; U.N. holds emergency meeting on Mali; report reveals 50 years of alleged sexual abuse of children by former BBC presenter Jimmy Savile.

Tredaptive was never approved in the U.S., but it has been sold in many countries around the world. A large, international study found the drug did not reduce the risk of heart disease and stroke, yet did trigger some serious side effects.

The outspoken artist, who has spent time in prison, tells WBUR that state media never report the truth: "It's like bad air all the time." Imprisonment, he says, was like "little beans dropped on the floor in some corner and people just forget about you. It's a very terrifying situation."

Kentucky legislative leaders say they haven't responded yet to Gov. Steve Beshear’s request to delay General Assembly redistricting in the 2013…

The creator and star of HBO's new series Girls addresses the backlash against the show, which follows four 20-somethings as they navigate the ups and downs of life in New York City. The second season premieres January 13.

Why do your fingers get pruney after a long water bath? Only a handful of researchers (ever) have looked into the finger-wrinkling experience. Reporting in the journal Biology Letters, researchers make the case for finger wrinkles as treads — wet wrinkled fingers seem to grip better than wet smooth ones.

Vice President Joe Biden met with members of the National Rifle Association and other supporters of gun rights yesterday. But what will come of the talks? Host Michel Martin checks in on that and more with the 'Barbershop' guys.

Juliann Garey's novel, Too Bright to Hear Too Loud to See, is a searing exploration of mental illness. Author Ellen Forney says it's a vivid and accurate depiction of bipolar disorder.

The Food and Drug Administration must review all new tobacco brands, and changes to existing ones, under a 2009 law giving the agency jurisdiction over tobacco. But the FDA has yet to approve any products under the new system, leaving some cigarette makers frustrated with the pace.